| JYSB2500035 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | Supplementary Application | 2025-02-13 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
| JYSB2300087 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | Supplementary Application | 2023-05-09 | | Novartis Pharma Schweiz AG | | | view |
| JYSB2300066 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | Supplementary Application | 2023-04-14 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
| JYSB2300065 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | Supplementary Application | 2023-04-14 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novartis Pharma Schweiz AG | | | view |
| JYSB2300015 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | Supplementary Application | 2023-02-03 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
| CXSS2300004 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-29 | | QILU Pharmaceutical Co Ltd | | | view |
| JYSB2200118 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | Supplementary Application | 2022-07-07 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
| JYSZ2200031 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | License Renew | 2022-07-06 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novartis Pharma Schweiz AG | | | view |
| JXSL2200083 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(3.3) | Import Drug Application | 2022-06-13 | | Samsung Bioepis NL BV | | | view |
| JXSL2101039 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(2.1) | Import Drug Application | 2021-06-07 | | F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd | | | view |
| JYSZ2100514 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | License Renew | 2021-05-10 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
| CXSL2101029 | 重组抗VEGF人源化单克隆抗体Fab片段注射液 | ranibizumab | Injection | Biological Products(3.3) | New Drug Application | 2021-04-21 | | Jecho Biopharmaceuticals Co Ltd | | | view |
| JXSS2000044 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Novartis Pharma Schweiz AG | Certificate Issued | 2021-08-17 | view |
| JXSS2000047 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | Certificate Issued | 2021-08-17 | view |
| JXSS2000046 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Novartis Pharma Schweiz AG | Certificate Issued | 2021-08-17 | view |
| JXSS2000045 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | Certificate Issued | 2021-08-17 | view |
| JXSS2000038 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-10 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | Certificate Issued | 2021-08-17 | view |
| JXSL2000131 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products(3.3) | Import Drug Application | 2020-07-17 | 上海艾迈医疗科技有限公司 | Shanghai AffaMed Therapeutics Co Ltd;Affamed Therapeutics (HK) Ltd | In Review | 2020-07-16 | view |
| JYSB2000311 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | Supplementary Application | 2020-06-24 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | Filed | 2020-06-24 | view |
| JYSB2000301 | 雷珠单抗注射液 | ranibizumab | Injection | Biological Products | Supplementary Application | 2020-06-22 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Novartis Pharma Schweiz AG | Filed | 2020-06-24 | view |
